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ABSTRACT
This study was conducted to shed light on the so far
unexplored intracellular mechanisms underlying negative mod-
ulation of Leydig cell steroidogenesis by histamine (HA). Using
the MA-10 cell line and highly purified rat Leydig cells as
experimental models, we examined the effect of the amine on
biochemical steps known to be modulated by HA or involved in
LH/hCG action. In agreement with previous findings, HA at 10
lM showed a potent inhibitory effect on hCG-stimulated steroid
synthesis, regardless of the gonadotropin concentration used.
Moreover, HA decreased not only LH/hCG-induced cAMP
production but also steroid synthesis stimulated by the perme-
able cAMP analog dibutyryl cAMP (db-cAMP). Considering the
post-cAMP sites of HA action, it is shown herein that HA
markedly inhibited db-cAMP-stimulated steroidogenic acute
regulatory (STAR) protein expression, as well as steps catalyzed
by P450-dependent enzymes, mainly the conversion of choles-
terol to pregnenolone by cholesterol side-chain cleavage
enzyme (CYP11A). The antisteroidogenic action of HA was
blocked by addition of the phospholipase C (PLC) inhibitor
U73122, and HA significantly augmented inositol triphosphate
(IP3) production, suggesting a major role for the PLC/IP3
pathway in HA-induced inhibition of Leydig cell func-
tion. Finally, HA increased nitric oxide synthase (NOS) activity,
and the NOS inhibitor NG-nitro-L-arginine methyl ester
(L-NAME) markedly attenuated the effect of the amine on
steroid synthesis. On the basis of our findings, HA antagonizes
the gonadotropin action in Leydig cells at steps before and after
cAMP formation. NOS activation is the main intracellular
mechanism by which HA exerts its antisteroidogenic effects.
histamine, Leydig cells, nitric oxide, testis, testosterone
INTRODUCTION
Histamine (HA) is a monoamine neurotransmitter synthe-
sized exclusively by histidine decarboxylase (HDC) in most
mammalian tissues. It has a role in the pathology and
physiology of diverse organs [1], including the male and
female reproductive systems. As regards the former, HA has
been proven to be synthesized in the testis of several species [2,
3]. This locally produced HA would then exert effects on
various testicular cell types, considering the recent studies [3–
6] indicating expression of HA receptor subtypes 1 and 2
(HRH1 and HRH2, respectively) in germinal and peritubular
cells, as well as macrophages and Leydig cells. In this respect,
HA was shown to stimulate steroidogenesis and to potentiate
the effects of LH in testicular parenchyma of the golden
hamster [7]. Recently, our group extended those observations,
reporting a dual concentration-dependent effect of the amine on
steroid biosynthesis in MA-10 murine Leydig cells and in
purified rat Leydig cells [6]. These results revealed a novel
unreported biological activity of HA in the testis, namely, the
negative modulation of steroid synthesis via HRH1. So far, the
intracellular mechanisms responsible for this inhibitory action
have not been fully characterized, to our knowledge.
Nitric oxide (NO) is a diffusible and short-lived free radical
gas known to have a diverse range of cellular targets [8, 9]. It is
synthesized from L-arginine by the action of NO synthase
(NOS), an enzyme existing in three isoforms. Neuronal NOS
(nNOS or NOS I, official symbol NOS1) and endothelial NOS
(eNOS or NOS III, official symbol NOS3) are responsible for
the continuous basal release of NO, and their enzymatic
activities are regulated by changes in intracellular concentra-
tions of free Ca2
þ
[10, 11]. A third isoform is an inducible
calcium-independent form (iNOS or NOS II, official symbol
NOS2) that is regulated at the transcriptional level. Its
expression can be induced in many cell types by cytokines
and lipopolysaccharide (LPS) [12, 13]. Among its numerous
and diverse biological actions, NO has been shown to regulate
several functions within the male reproductive system under
physiological and pathological conditions [14]. With particular
regard to the testis, previous results from our laboratory
showed that exogenously supplied NO potently inhibits LH/
hCG-induced steroidogenesis in MA-10 cells and in rat Leydig
cells; specifically, NO was demonstrated to directly affect
cytochrome P450-dependent enzymes involved in the steroido-
genic pathway, mainly cholesterol side-chain cleavage enzyme
(CYP11A) [15]. In agreement, more recent studies [16–18]
indicate that LPS-stimulated testicular macrophages can
negatively modulate testosterone production by rat and mouse
Leydig cells through paracrine NO signaling. There is also
evidence to suggest that Leydig cells have the capacity to
generate NO. In this respect, expression of neuronal,
endothelial, and/or inducible NOS isoforms has been reported
in human, rodent, and pig Leydig cells [19–23], and NO
production has been detected by means of biochemical
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quantitative methods [21]. Further studies [24, 25] revealed the
presence of a testis-specific variant of NOS1 (TnNOS) in
human and mouse Leydig cells, in which it is encoded by the
activity of a specific gene promoter. Of special interest,
although NO can have a role as intracellular mediator of HA
actions in various nonsteroidogenic cell types [26–28], the
possibility that a similar situation might exist in Leydig cells
has not been explored, to our knowledge.
In the present study, we aimed to identify the intracellular
events underlying inhibition of Leydig cell steroidogenesis by
HA and, in doing so, to examine the possible involvement of
endogenously produced NO in the mechanism of action of the
amine. Taken collectively, our results reveal multiple sites of
HA action in the inhibition of Leydig cell steroidogenesis and
indicate that NOS activation is the main intracellular
mechanism by which HA exerts its antisteroidogenic effects.
The rising prevalence of allergic diseases and the subsequent
increase in the use of anti-HA medication underline the
significance of this study.
MATERIALS AND METHODS
Materials
Purified hCG (CR-127, 14 900 IU/mg) was a gift from the National
Hormone and Pituitary Program, National Institute of Diabetes and Digestive
and Kidney Diseases (NIDDK), National Institutes of Health (NIH) (Bethesda,
MD). Sodium iodide I 125 (specific activity, 600 Ci/mmol) and [3H]-inositol
(specific activity, 25 Ci/mmol) were purchased from Perkin Elmer Life and
Analytical Sciences (Boston, MA). [3H]-L-arginine (specific activity, 49 Ci/
mmol) was purchased from Amersham International (Buckinghamshire,
England). Histamine dihydrochloride, dibutyryl cAMP (db-cAMP), 20-O-
monosuccinyladenosine-3 0,5 0-cyclic monophosphate tyrosyl methyl ester
(TME-cAMP), 22R-hydroxycholesterol (22R-OH-Ch), pregnenolone (P
5
),
NG-nitro-L-arginine methyl ester (L-NAME), protease inhibitors leupeptin and
PMSF, and phospholipase C (PLC) inhibitor U73122 were purchased from
Sigma Chemical Co (St. Louis, MO). Collagenase was purchased from
Worthington (Freehold, NJ). Cell culture supplies and plasticware were
obtained from Gibco-BRL (Gaithersburg, MD) and Corning (Corning, NY),
respectively. The resins AG-I-X8 (formate form) and AG-50W-X8 (hydrogen
form) were from Bio-Rad Laboratories, Inc. (Hercules, CA). The TME-cAMP
was radiolabeled with Na125I in our laboratory by the method of chloramine T
(specific activity, 600 Ci/mmol) previously described by Piroli et al. [29]. The
specific antibody for cAMP was provided by Dr. A.F. Parlow (National
Hormone and Pituitary Program of the NIDDK). Antibodies for progesterone
and testosterone were a gift from Dr. G.D. Niswender (Animal Reproduction
and Biotechnology Laboratory, Colorado State University, Fort Collins). Anti-
b-tubulin monoclonal antibody E7 was purchased from Developmental Studies
Hybridoma Bank (Iowa City, IA). Dr. Douglas M. Stocco (Texas Tech
University Health Science Center, Lubbock) and Dr. Walter L. Miller
(University of California, San Francisco) generously provided steroidogenic
acute regulatory (STAR) protein antibody. Anti-CYP11A antibody was kindly
donated by Dr. Marta Tesone (Institute of Biology and Experimental Medicine-
CONICET, Buenos Aires, Argentina). Other reagents used were of the best
grade available and were obtained from commonly used suppliers.
Cellular Culture of MA-10 Leydig Cells
The MA-10 line (kindly provided by Mario Ascoli, University of Iowa,
Iowa City) is a clonal strain of Leydig tumor cells that secretes progesterone
rather than testosterone as a major steroid and provides a suitable model system
for the study of gonadotropin actions and regulation of differentiated functions
of Leydig cells. The origin and handling of MA-10 cells have been described
[30, 31]. Cells were plated in 24 3 16-mm-well plates on Day 0 at a density of
1.25 3 105 cells/well and in a total volume of 1 ml of growth medium
(Waymouth MB752/1 [Sigma-Aldrich Corp., St. Louis, MO], modified to
contain 1.1 g/l of NaHCO
3
, 20 mM Hepes, 50 lg/ml of gentamycin, and 15%
horse serum, pH 7.4). The cells were maintained in a humidified atmosphere
containing 5% CO
2
and were used on Day 3. At this time, the cell density was
approximately 5 3 105 cells/well. On this day, the cells were washed twice with
1 ml of serum-free medium supplemented with 1 mg/ml of BSA (378C, assay
medium). Incubations were performed in a total volume of 0.5 ml of assay
medium at 378C with the corresponding additions as shown in each figure
herein. After 5 h, media were removed, and progesterone was measured by RIA
as previously described [32]. The intraassay and interassay variations were
8.0% and 14.2%, respectively. In experiments assessing the effect of PLC
inhibitor U73122 or NOS inhibitor L-NAME on HA antisteroidogenic actions,
cells were incubated with the specific inhibitor for 30 min before HA treatment
for an additional 4.5 h. All experiments were performed in triplicate with at
least three different cell line batches or passage numbers of cells, and similar
results were obtained each time.
Preparation of Rat Leydig Cells
For all experiments, Leydig cells were isolated from a pool of 16 testes
obtained from eight adult Sprague-Dawley rats (60 days old, 200–250 g,
Charles River descendants, Animal Care Laboratory, Institute of Biology and
Experimental Medicine) as previously described [6, 33, 34]. Animals were
housed in groups in an air-conditioned room with lights-on from 0700 to 1900
h. They were given free access to laboratory chow and tap water. Animals were
killed by decapitation according to protocols for animal use approved by the
institutional animal care and use committee (Institute of Biology and
Experimental Medicine–CONICET), which follows NIH guidelines.
Briefly, testes were decapsulated and dispersed by shaking (20 min, 80
cycles/min, 348C) in 50-ml polypropylene tubes (Falcon, Cowley, England)
containing 0.05% collagenase in medium 199 (M199) supplemented with 0.1%
BSA (1 ml/testis). The incubations with collagenase were terminated by 1:5
dilution using M199 supplemented with 0.1% BSA. The tubes were capped and
inverted several times. The seminiferous tubules were allowed to settle for 1
min, and the supernates were collected by aspiration using a pipette. The
interstitial cells were filtered through Nitex monofilament (BD Biosciences
Labware, Beford, MA). The tubes containing the settled seminiferous tubules
were refilled with M199 supplemented with 0.1% BSA, and the same
procedure was repeated. After filtering, the cells were pelleted by centrifugation
at 800 3 g for 5 min and washed twice. These interstitial cell pellets were then
resuspended in 5 ml of a 1.7 mM Tris, 140 mM NH
4
Cl solution, pH 7.2, as
previously described [6] and incubated for 10 min at 378C. Incubation was
terminated by dilution with M199 and followed by centrifugation. This
procedure eliminates any interference due to the presence of red blood cells and
does not affect the cell response to gonadotropin stimulation. The cell pellets
were then resuspended in 10 ml of M199–0.1% BSA. Testicular macrophages
were separated by differential attachment to plastic culture plates (348C, 15
min). The plates were washed five times with PBS to remove unattached cells.
These were centrifuged at 800 3 g for 5 min. The cell pellets were resuspended
in M199–0.1% BSA and were purified by fractionation on a three-layer Percoll
(GE Healthcare Bio-Sciences, Uppsala, Sweden) density gradient (26%, 34%,
and 60%), which was centrifuged at 800 3 g for 30 min. The purity of Leydig
cells obtained was greater than 87% as assessed by histochemical staining for
3b-hydroxysteroid dehydrogenase activity [35]. Less than 1.7% and 1.2% of
the contaminating cells in the Leydig cell preparations were positive
macrophages for ED-1 and ED-2 antigens, respectively [36]. The remaining
cell types had the morphology of peritubular cells or endothelial cells. As
regards mast cells, these are normally located in the testicular capsule, which is
removed at the beginning of the procedure.
The pellets, enriched in Leydig cells, were gently resuspended in M199
containing 1.2 g/l of NaHCO
3
, 20 mM Hepes, 0.1 mM 1-methyl-3-
isobutylxanthine, and 0.5% BSA. Incubations were performed in plastic tubes
in a volume of 500 ll (53105 cells/tube) at 348C with shaking for 5 h. The
samples were then centrifuged at 800 3 g for 5 min, and the supernatants were
used to determine testosterone level by RIA [6]. The intraassay and interassay
variations were 7.3% and 13.2%, respectively.
Dose-response experiments were performed to determine the optimal
concentration of hCG to stimulate the cells. Testosterone production was
maximal in the presence of 1 ng/ml of hCG. Therefore, all subsequent
experiments in rat Leydig cells were performed using this hCG concentration.
In experiments assessing the effect of NOS inhibitor L-NAME on HA
antisteroidogenic actions, cells were incubated with L-NAME for 30 min before
HA treatment for an additional 4.5 h. All experiments were repeated with at
least three different preparations of Leydig cells obtained from different sets of
animals. In each experiment, values for a given treatment group were obtained
using triplicate tubes.
Determination of Intracellular cAMP in MA-10 Leydig Cells
The method for the determination of intracellular cAMP in the MA-10 cell
line has been previously published [6, 37]. After a 20-min incubation of the
cells in the presence of the corresponding additions, the plates were placed on
ice, and the medium was aspirated. Next, 0.5 ml of cold distilled water was
added to each well, and the cells were scraped and disrupted by ultrasonic
oscillation. The samples were heated for three periods of 1 min in boiling water
to destroy endogenous protein kinase. After centrifugation in an Eppendorf
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microfuge (Brinkmann Instruments, Westbury, NY) for 3 min, samples were
diluted using 50 mM sodium acetate buffer (pH 6.0). Unknown samples and
standards were acetylated and assayed by RIA using the method described
previously [15]. The interassay and intraassay variations of coefficients were
lower than 10%.
Determination of [3H]-Inositol Phosphates in MA-10 Cells
Inositol phosphates (IPs) were measured as described previously [6, 38].
Cells were incubated in assay medium A (Waymouth MB752/1 containing 1.1
g/l of NaHCO
3
, 20 mM Hepes, and 1 mg/ml of albumin, pH 7.4, 378C) with 4
to 5 lCi/ml of [3H]-inositol for 24 h before the experiment. At the end of the
labeling period, the cells were washed five times with 2-ml aliquots of assay
medium B (Waymouth MB752/1 without NaHCO
3
but containing 20 mM
Hepes and 1 mg/ml of albumin, pH 7.4, 378C). Cells were then preincubated for
15 min in 2 ml of assay medium B (378C) containing 20 mM LiCl. At the end
of this period, 10 lM HA or 10 mM NaF was added. After a 30-min incubation,
the wells were placed on ice, and the medium was quickly aspirated and
replaced with 0.5 ml of ice-cold 0.5 M HClO
4
. The cells were scraped with a
rubber policeman and transferred to tubes. The wells were then washed with 0.7
ml of ice-old HClO
4
, and this wash was combined with the previous extract.
After a 30-min incubation on ice, the extracts were centrifuged. Collected





was removed by centrifugation, and supernatants were
mixed with 0.5 ml of 100 mM inositol. The volume was adjusted to 5 ml with
H
2
O, and supernatants were chromatographed on 0.5 3 3.0-cm Dowex (Bio-
Rad Laboratories, Inc.) columns (formate form). The columns had been
prewashed with 10 ml of 10 mM inositol. After adding the samples, the
columns were sequentially washed with 15 ml of 10 mM inositol (to wash
residual [3H]-inositol), 5 ml of 5 mM sodium borate/60 mM sodium formate (to
elute glycerophosphoinositol), 5 ml of 0.1 M formic acid/0.2 M ammonium
formate (to elute inositol monophosphate, IP
1
), 5 ml of 0.1 M formic acid/0.4
M ammonium formate (to elute inositol bisphosphate, IP
2
), and 5 ml of 0.1 M
formic acid/1.0 M ammonium formate (to elute inositol trisphosphate, IP
3
).
Eluted fractions were transferred to vials containing scintillation cocktail
(Optiphase Hisafe III scintillation liquid; Wallac, Gaithersburg, MD), and
radioactivity was determined by liquid scintillation counting (Tri-carb 1600TR;







activity was normalized to total [3H]-inositol
recovered from the initial water wash of the columns corresponding to the
intracellular [3H]-inositol pool.
Preparation of MA-10 Cell Postmitochondrial Fractions
and Measurement of NOS Activity
MA-10 cells were washed five times with ice-cold PBS and then scraped
and resuspended in 0.5 ml/plate of ice-cold buffer containing 50 mM Tris-HCl,
pH 7.4, 0.25 M sucrose, 10 lg/ll of leupeptin, 1 mM dithiotreitol (DTT), 5 mM
NaF, 1 mM PMSF, and 50 mM sodium orthovanadate (homogenization buffer).
Cell suspensions were then forced through a syringe using a 21-gauge needle
60 times and centrifuged at 900 3 g for 10 min at 48C. Supernatants were
collected in Eppendorf tubes and centrifuged at 9000 3 g for 15 min at 48C.
NOS activity was subsequently determined by monitoring the conversion of
[3H]-L-arginine to [3H]-L-citrulline as previously described [39]. In each assay,
70 ll of MA-10 cell extract (postmitochondrial fraction) was added to 70 ll of
buffer containing 50 mM Tris-HCl, pH 7.4, 10 lg/ll of leupeptin, 1 mM DTT,
5 mM NaF, 1 mM PMSF, 50 mM sodium orthovanadate, 1 mM NADPH, 1
mM CaCl
2
and 90 nM [3H]-L-arginine (400 000 cpm). After incubation for 30
min at 378C, samples were applied to previously equilibrated columns of 1 ml
of Dowex AG-50W-X8 resin (100–200 mesh, Hþ form; Bio-Rad Laboratories,
Inc.). [3H]-L-citrulline was eluted with 3 ml of distilled water and then
quantified in the Tri-carb 1600TR liquid scintillation counter. NOS activity is
indicated in picomoles of [3H]-L-citrulline formed per milligram of protein per
30 min.
Western Blot Analysis and Immunodetection of Proteins
After a 4-h incubation in the presence of the corresponding additions, total
cellular protein was obtained by placing MA-10 cells in lysis buffer (10 mM
Tris-HCl, pH 7.4, 0.25 M sucrose, 0.1 M EDTA) containing a protease
inhibitor cocktail (10 lg/ll of leupeptin, 5 mM NaF, 2.5 mM PMSF, and 50
mM sodium orthovanadate), followed by brief sonication. Protein concentra-
tions were measured using the Bradford assay (Bio-Rad Laboratories, Inc.,
Hercules, CA) for total protein. Equal amounts of protein per sample (30–40
lg) were loaded onto a 15% (w/v) SDS-polyacrylamide gel (Mini Protean III
System; Bio-Rad Laboratories, Inc.). Electrophoresis, transfer of proteins to
polyvinylidene fluoride membranes, and immunodetection of STAR and
CYP11A were performed under optimized conditions [40–42]. The intensity of
immunospecific bands was quantified using ImageJ software (NIH, Bethesda,
MD) [43, 44]. To correct for equal loading and blotting, all blots were reprobed
with anti-b-tubulin antibody.
Statistical Analysis
All experiments performed herein were repeated at least three times, and the
data were pooled. If heterogeneity of variance was detected by Bartlett test, this
was reduced by logarithmic transformation of the data before analysis. These
data were then subjected to one-way ANOVA followed by Newman-Keuls test
for multiple-range comparisons. P , 0.05 was considered statistically
significant.
RESULTS
Inhibitory Effect of HA on hCG-Stimulated MA-10 Leydig
Cell Progesterone Production
Our previous results demonstrated that HA can exert a
noncytotoxic inhibitory effect on steroidogenesis in MA-10
cells under basal conditions and after acute stimulation with a
maximally efficient hCG concentration (10 ng/ml, 5 h) [6]. To
further characterize the effect of HA on hCG-stimulated
progesterone production, MA-10 cells were incubated with
increasing hCG concentrations (0.5–25 ng/ml) in the absence
or presence of 10 lM HA for 5 h. As shown in Figure 1, the
inhibitory action of HA was observed at all hCG concentrations
tested, with maximum inhibition observed in the presence of
hCG concentrations of 5 ng/ml or higher (70% inhibition, on
average). The HA affected the maximal steroidogenic capacity
of the cells but not the median effective concentration of hCG
(1.8 ng/ml) required to stimulate progesterone synthesis.
Involvement of PLC Activation and IP
3
Production
in HA-Mediated Inhibition of Progesterone Synthesis
in MA-10 Cells
We demonstrated that reduction of steroid levels by HA at
10 lM would be solely mediated via HRH1 activation. It is
well known that HRH1 couples to PLC via the GTP-binding
protein Gq in a wide variety of tissues [45]. Therefore, it was of
FIG. 1. Inhibitory effect of 10 lM HA on LH/hCG-stimulated progester-
one production in MA-10 cells. Each bar shows the mean 6 SEM of three
independent experiments performed with triplicate samples. * P , 0.05
vs. same treatment in the absence of HA; *** P , 0.001 vs. same
treatment in the absence of HA.
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interest to evaluate the involvement of PLC in HA-induced
inhibition of steroidogenesis. MA-10 cells were incubated with
10 lM HA in the absence or presence of the PLC inhibitor
U73122 (10 lM) with or without hCG (10 ng/ml) for 5 h at
378C. Under basal and hCG-stimulated conditions, U73122
completely reversed the inhibitory effect of HA on progester-
one synthesis (Fig. 2). No detectable changes in progesterone
levels were observed for U73122 alone (data not shown). We
also studied whether HA could modulate accumulation of IPs.
MA-10 cells were incubated with or without 10 lM HA for 30
min at 378C. Sodium fluoride (10 mM) was used as a positive







levels in MA-10 cells.
Sites of Action of HA on Steroidogenesis in MA-10 Cells
To characterize the site(s) of HA action in MA-10 cells, we
examined the effect of the amine on biochemical steps known
to be modulated by HA or involved in LH/hCG action.
Considering that cAMP is the main second messenger in the
LH/hCG signaling pathway, we first evaluated the capacity of
HA to negatively regulate cAMP production. MA-10 cells
were incubated with or without 10 lM HA in the absence or
presence of 10 ng/ml of hCG for 20 min at 378C. As shown in
Figure 3 (black bars), HA induced a significant decrease in LH/
hCG-stimulated cAMP production (46% inhibition). Effects on
basal cAMP levels were nondetectable. We then studied the
effect of HA on progesterone synthesis stimulated by db-
cAMP, a membrane-permeable analog of cAMP. MA-10 cells
were incubated with db-cAMP (1 mM) in the absence or
presence of 10 lM HA for 5 h at 378C. The HA potently
inhibited progesterone production stimulated by the nucleotide
to a similar extent (73% inhibition) as that observed with the
hCG (Fig. 3, white bars).
To further identify the post-cAMP site(s) of HA action, we
examined the effect of the amine on the expression of the
STAR protein, which mediates the rate-limiting step in steroid
hormone biosynthesis (i.e., the delivery of cholesterol from the
outer to the inner mitochondrial membrane) [46]. As shown in
Figure 4, treatment of MA-10 cells with HA caused a marked
reduction in db-cAMP-stimulated STAR protein expression.
We subsequently incubated MA-10 cells with two different
steroid substrates, namely, 22R-OH-Ch, a cholesterol substrate
derivative that does not need an assisted process to be delivered
to the inner mitochondrial membrane, and P
5
. As shown in
Figure 5, HA exerted a significant inhibitory effect on
progesterone synthesis in the presence of 22R-OH-Ch (75%
inhibition), but such effect was no longer observed in the
presence of P
5
. Considering that CYP11A catalyzes the
conversion of cholesterol to P
5
, we also evaluated the effect
of HA treatment on the expression of this enzyme. Figure 6
shows that HA did not modify db-cAMP-induced CYP11A
expression.
Effect of the NOS Inhibitor L-NAME on HA-Induced
Inhibition of Progesterone Synthesis in MA-10 Cells
To examine the possibility that NO may be involved in HA-
induced inhibition of steroidogenesis in MA-10 cells, L-
NAME, a specific inhibitor of NOS activity, was tested for
FIG. 2. Effect of the PLC inhibitor U73122 on 10 lM HA modulation of
basal and hCG-stimulated progesterone production in MA-10 cells. Each
bar shows the mean 6 SEM of three independent experiments performed
with triplicate samples. Different letters above the bars indicate that the
groups differ significantly at least at P , 0.05.








Control 36.04 6 0.04a 8.09 6 0.15a 6.68 6 0.28a
NaF (10 mM) 307.19 6 29.24b 67.29 6 1.67b 113.59 6 3.63b
HA (10 lM) 75.58 6 2.41c 20.26 6 0.36c 13.53 6 1.02c
a-cDifferent letters in each column indicate that the groups differ significantly at least at P , 0.05.
FIG. 3. Effects of 10 lM HA on hCG-stimulated cAMP production (black
bars) and db-cAMP-stimulated progesterone biosynthesis (white bars) in
MA-10 cells. Intracellular cAMP levels were measured as described in
Materials and Methods. Basal cAMP levels were a mean 6 SEM of 1.87 6
0.16 pmol cAMP/106 cells, n ¼ 3. Each bar shows the mean 6 SEM of
three independent experiments performed with triplicate samples. * P ,
0.05 vs. hCG alone. Basal progesterone levels were a mean 6 SEM of
1.42 6 0.20 ng/106 cells, n¼ 3. Each bar shows the mean 6 SEM of three
independent experiments performed with triplicate samples. *** P ,
0.001 vs. db-cAMP alone.
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its ability to reverse the effects of the amine. MA-10 cells were
incubated with L-NAME (1 mM), in the presence of 10 lM HA
with or without hCG (10 ng/ml) for 5 h at 378C. Figure 7
shows that L-NAME completely reversed HA-induced inhibi-
tion of basal progesterone production and potently attenuated
inhibition in the presence of hCG.
Stimulatory Effect of HA on NOS Activity in MA-10 Cells
To further confirm the participation of NO in the mechanism
of action of HA in MA-10 cells, we adopted a more direct
approach by studying whether the amine can activate NOS in
such cells. Incubations were performed in the absence or
presence of 10 lM HA for 5 h at 378C. Rat brain homogenate
was used as a positive control. As expected, HA significantly
increased NOS activity in MA-10 cells (2.5-fold over basal
value) (Fig. 8). Clearly, these results complement our
observations noted in the presence of L-NAME.
Sites of Action of HA on Steroidogenesis in Purified Rat
Leydig Cells
To show that the inhibitory effect of HA on steroidogenesis
was not exclusive for the MA-10 cell line, we studied the effect
of 10 lM HA on testosterone biosynthesis in a suspension of
highly purified normal rat Leydig cells. Figure 9 shows that
HA significantly reduced, in a comparable range (about 47%
decrease), testosterone synthesis stimulated with LH/hCG or
db-cAMP. Effects on cAMP levels were nondetectable under
basal conditions, but a 30% inhibition of hCG-induced cAMP
formation was observed (data not shown). Taken collectively,
these results indicate that the antigonadotropic action of HA is
predominantly exerted at a step (or steps) located beyond
cAMP formation, as observed for MA-10 cells. The inhibitory
effect of HA on testosterone synthesis was also observed in the
presence of 22R-OH-Ch and P
5
(45% and 30% inhibition,
respectively) (Fig. 10).
Effect of the NOS Inhibitor L-NAME on HA-Induced
Inhibition of Testosterone Production in Rat Leydig Cells
To confirm the involvement of NOS in the mechanism of
action of HA in rat Leydig cells, L-NAME was tested for its
ability to reverse the effects of the amine. Rat Leydig cells were
incubated with L-NAME (1 mM) in the presence of 10 lM HA
with or without hCG (1 ng/ml). Figure 11 shows that L-NAME
completely reversed HA-induced inhibition of basal testoster-
one production and potently attenuated inhibition in the
presence of hCG.
DISCUSSION
Convincing evidence has accumulated in recent years that
locally produced HA has a role as autocrine/paracrine
modulator of testicular steroidogenesis in several experimental
models in vivo and in vitro [4–7, 47]. Because anti-HA drugs
target HA receptors, we believe that it is essential to increase
our limited knowledge regarding HA-ergic regulation of
testicular functions to avoid possible unexpected adverse
effects of such substances in the testis. Specifically, the present
study was conducted to shed light on the so far unexplored
intracellular mechanisms underlying negative modulation of
steroidogenesis by HA.
In agreement with previous findings, HA at 10 lM showed
a potent inhibitory effect on hCG-stimulated steroid production
in MA-10 cells and rat Leydig cells, regardless of the
gonadotropin concentration used [6]. The two major routes of
HA metabolism result in imidazole products, which are known
to affect steroidogenesis. However, our previous findings
FIG. 4. Effect of 10 lM HA on STAR protein levels. After treatments, MA-
10 cells were lysed and subjected to Western blot analysis as described in
Materials and Methods. Data were normalized to the 55-kDa internal
control b-tubulin. A) Representative Western blot of STAR protein. B)
Quantitation of protein levels by scanning densitometry. Each bar shows
the mean 6 SEM of three independent experiments performed with
triplicate samples. Different letters above the bars indicate that the groups
differ significantly at least at P , 0.05.
FIG. 5. Effects of 10 lM HA on progesterone formation stimulated by
22R-OH-Ch and P
5
in MA-10 cells. Each bar shows the mean 6 SEM of
three independent experiments performed with triplicate samples.
Different letters above the bars indicate that the groups differ significantly
at least at P , 0.05.
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showed complete blockage of 10 lM HA-induced inhibition of
basal and stimulated steroidogenesis in the presence of the
specific HRH1 antagonist pyrilamine [6]. In agreement, similar
results have been recently reported in wall lizard Leydig cells
[4]. These results suggest that imidazole metabolites would not
be involved in HRH1-mediated inhibition of Leydig cell
steroidogenesis by HA. However, we cannot completely rule
out the possibility that imidazoles may exert effects on Leydig
cell steroidogenesis via HRH1-independent mechanisms.
The antisteroidogenic action of HA was blocked by addition
of the PLC inhibitor U73122, and HA significantly augmented
IP
3
production, suggesting a major role for the PLC/IP
3
pathway in HA-induced inhibition of Leydig cell function. It is
well known that HRH1 couples to PLC via the GTP-binding
protein Gq in a wide variety of tissues [45]. Therefore, these
results complement our former studies [5, 6] indicating that, in
murine MA-10 cells and rat Leydig cells, reduction of steroid
levels by HA is mediated via HRH1 activation.
The fact that steroid production was similarly and
dramatically reduced in HA-treated cells stimulated with
hCG or db-cAMP indicates a predominant action of HA at a
biochemical step (or steps) located beyond cAMP formation. In
this regard, HA provoked a marked reduction in db-cAMP-
FIG. 8. Effect of 10 lM HA on NOS activity in MA-10 cells. NOS activity
was determined as described in Materials and Methods. Rat brain
homogenate was used as a positive control. Each bar shows the mean
6 SEM of three independent experiments performed with triplicate
samples. ** P , 0.01 vs. control. *** P , 0.001 vs. control. Prot, protein.
FIG. 9. Effects of 10 lM HA on testosterone production stimulated by
hCG or db-cAMP in rat Leydig cells. Each bar shows the mean 6 SEM of
three independent experiments performed with triplicate samples.
Different letters above the bars indicate that the groups differ significantly
at least at P , 0.05.
FIG. 6. Effect of 10 lM HA on CYP11A protein levels. After treatments,
MA-10 cells were lysed and subjected to Western blot analysis as
described in Materials and Methods. Data were normalized to the 55-kDa
internal control b-tubulin. A) Representative Western blot of CYP11A
protein. B) Quantitation of protein levels by scanning densitometry. Each
bar shows the mean 6 SEM of three independent experiments performed
with triplicate samples. Different letters above the bars indicate that the
groups differ significantly at least at P , 0.05.
FIG. 7. Effect of the NOS inhibitor L-NAME on 10 lM HA modulation of
basal and hCG-stimulated progesterone production in MA-10 cells. Each
bar shows the mean 6 SEM of three independent experiments performed
with triplicate samples. Different letters above the bars indicate that the
groups differ significantly at least at P , 0.05.
HA INCREASES NOS ACTIVITY IN LEYDIG CELLS 149
stimulated STAR protein expression, implying that HA would
affect intramitochondrial cholesterol transport. Furthermore,
incubation of the cells with 22R-OH-Ch, which does not need
an assisted process to be delivered to the inner mitochondrial
membrane, did not reverse the antisteroidogenic effect of HA,
suggesting the existence of at least one additional site of HA
action. In the MA-10 cell model, the effect of HA was
prevented when exogenously added P
5
was used as a substrate
for progesterone synthesis. Considering that the truncated
steroid pathway in MA-10 cells comprises two enzymatic
steps, it is most likely that HA antagonizes the gonadotropin
hormonal action by decreasing CYP11A activity in the inner
mitochondria, while 3b-hydroxysteroid dehydrogenase activity
would not be affected. Further experiments allowed us to rule
out the possibility that HA may also inhibit CYP11A
expression, at least after the treatment period that we evaluated.
In rat Leydig cells, HA inhibited P
5
-stimulated testosterone
synthesis, in clear contrast to our observations in MA-10 cells.
This discrepancy may be attributable to an HA-induced
decrease in the activity of 17 alpha-hydroxylase/C17,20-lyase
(CYP17), a P450-dependent enzyme acting beyond progester-
one in the pathway leading to testosterone biosynthesis in rat
Leydig cells.
NO has been extensively demonstrated to inhibit steroid
biosynthesis by reversibly binding to the heme group of
cytochrome P450-dependent enzymes of the steroidogenic
pathway [15, 48, 49]. There is evidence in the literature
suggesting a role for intracellular NO as a mediator of HA
actions in various nonsteroidogenic cell types [26–28]. We
speculated that a similar situation might exist in Leydig cells
and conducted a series of experiments to investigate this
possibility. Results presented herein show that L-NAME, a
widely used NOS inhibitor, completely reversed the effect of
HA on basal steroidogenesis and markedly attenuated the effect
of the amine on hCG-stimulated steroid synthesis. Moreover,
HA augmented NOS activity in MA-10 cells. Taken together,
these findings strongly suggest the involvement of endoge-
nously produced NO in the mechanism of HA-dependent
inhibition of Leydig cell steroidogenesis. Activation of several
receptor systems that lead to endothelial or neuronal NO
synthesis has been shown to involve G protein-coupled
signaling via PLC activation and production of IP
3
[50, 51].
NOS1 and NOS3 isoforms are expressed in Leydig cells [19,
20, 23]. Therefore, it could be speculated that a similar
pathway may be responsible for the observed augmentation of
NOS activity by HA. This is further supported by our findings
indicating the essential role of the PLC/IP
3
pathway in HA-
induced inhibition of Leydig cell function.
Our results seem to conflict with the hypothesis proposed by
Weissman and coworkers [17] suggesting that Leydig cells
have no endogenous NO-generating system, while testosterone
production is highly sensitive to exogenous NO. However,
these authors reported remarkably low NOS activity in Leydig
cells, as well as a low level of expression of NOS3. We show
herein that L-NAME, at the concentration used by Weissman
and coworkers, almost completely counteracted the inhibitory
effects of HA on steroid synthesis. Indeed, HA-induced
inhibition of stimulated steroidogenesis was limited to less
than 30% in cells treated with L-NAME. We also detected NOS
activity in MA-10 cells in the same range as Weissman and
coworkers reported for normal rat Leydig cells, and recent
studies have provided clear evidence that Leydig cells not only
express the NOS subtype that is specific to the male gonad but
also respond to stimulation of the brain-testicular pathway by
producing increasing levels of this enzyme [52]. Therefore, on
the basis of these findings, we propose that Leydig cells have
an NO-generating system on which testicular factors may exert
a paracrine and/or autocrine regulatory effect. We demonstrate
herein that HA could be one of those factors. However, we do
not exclude the possibility of a paracrine effect of macrophage-
related NO on Leydig cell steroidogenesis, as suggested by
Weissman et al. [17] and by Hales 18]. In this regard, the
existence of functional HRH1 has been recently demonstrated
in testicular macrophages [4].
Of particular interest, there is evidence to suggest an
intracellular NO-mediated inhibition of STAR protein expres-
sion in Leydig cells [52, 53], implying the existence of an
additional site of NO action in the regulation of steroidogen-
esis. In view of these findings, it is tempting to speculate that
NO may at least partially account for the observed inhibitory
effects of HA on the expression of STAR protein, as well as the
activity of CYP11A. In MA-10 cells and in rat Leydig cells,
FIG. 10. Effects of 10 lM HA on testosterone formation stimulated by
22R-OH-Ch and P
5
in rat Leydig cells. Each bar shows the mean 6 SEM of
three independent experiments performed with triplicate samples.
Different letters above the bars indicate that the groups differ significantly
at least at P , 0.05.
FIG. 11. Effect of the NOS inhibitor L-NAME on 10 lM HA modulation
of basal and hCG-stimulated testosterone production in rat Leydig cells.
Each bar shows the mean 6 SEM of three independent experiments
performed with triplicate samples. Different letters above the bars indicate
that the groups differ significantly at least at P , 0.05.
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HA provoked a significant decline in LH/hCG-stimulated
cAMP production. This effect is probably not mediated by NO,
considering our previous findings indicating that the gas does
not modify basal or hCG-stimulated cAMP levels in MA-10
cells [15]. Therefore, it is possible that such decreased cAMP
generation may exert some contribution to the observed HA-
induced reduction in steroid synthesis under hormonal
stimulation independent of NOS activation. If this was the
case, it might help explain why L-NAME could not completely
counteract the effects of the amine on the steroidogenic
process. Because incubations of MA-10 cells and rat Leydig
cells for subsequent cAMP determination were performed in
the presence of the phosphodiesterase inhibitor isobutyl-
methylxanthine, it could be speculated that HA, acting via
HRH1, decreases adenylate cyclase (AC) activity. Consistent





) release has been recently reported
in A7r5 smooth muscle cells [54]. Moreover, Pereira et al. [55]
have reported that Ca2
þ
decreases the rate of cAMP accumu-
lation induced by hCG in MA-10 cells. Clearly, this hypothesis
requires further investigation.
Pap et al. [47] have reported that HDC-deficient mice
(homozygous for the Hdctm1Nagy allele, herein denoted as
Hdc) show reduced testis weight and elevated testicular
steroid levels compared with wild-type mice. Moreover,
Hdc/ mice show altered Leydig cell ultrastructure already
at the age of 7 days, when the testes have not yet descended
from the abdomen [47]. Gaytan et al. [56] have reported
simultaneous proliferation and differentiation of mast cells and
Leydig cells in the rat testis, suggesting the existence of
dynamic interactions between the two cell types. Considering
that the HA concentration in rat neonatal testes has been found
to be in the micromolar range [2], it could be speculated on the
basis of the observations by Pap and coworkers [47] that HA
has a role as a negative modulator of testicular steroidogenesis
in neonates. However, it is uncertain whether this is a direct
effect of HA on fetal Leydig cells, or if other testicular cell
types expressing HA receptors might be involved by paracrine
actions in the modulation of steroidogenesis. In this regard,
given that there are no reports (to our knowledge) on the
existence of functional HA receptors in fetal Leydig cells, it is
still open to debate whether these cells express such receptors
or whether they do so later in development. The normal HA
concentration in an adult rat testis is in the nanomolar range.
However, there is evidence to indicate that it can increase
significantly under stress conditions [57, 58]. This fact
highlights the importance of our experiments showing how
adult Leydig cells can respond to such increased HA
concentration, as well as the intracellular mechanisms
underlying this response. Considering that HA has also been
implicated in spermatogenesis, penile erection, and sexual
behavior [59–61], it seems that the amine has an integral role in
the regulation of male reproductive function that deserves
further investigation. Of note, studies [62, 63] have linked
testicular mast cells to the pathogenesis of testicular disorders.
Bearing this in mind, a potential role of HA in testicular
pathology associated with infertility should also be considered.
In conclusion, results presented herein demonstrate for the
first time (to our knowledge) that NOS activation is the main
intracellular mechanism by which HA exerts antisteroidogenic
actions in Leydig cells, suggesting a direct interaction between
HA and NO to modulate Leydig cell steroidogenesis. Most
important, HRH1 and NOS isoforms are found in other
testicular cell types such as peritubular cells, germ cells, and
macrophages [3, 4, 22, 23]. Therefore, it is possible that under
specific circumstances activation of NOS and subsequent NO
production comprise a general mechanism triggered by HA on
its multiple testicular target cells. This mechanism may have
important implications for male reproductive function under
physiological and pathological conditions.
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